Visa Equity Method Investments decreased by 6.5% to $999.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 13.6%, from $1.16B to $999.00M. Over 5 years (FY 2020 to FY 2025), Equity Method Investments shows an upward trend with a 34.0% CAGR.
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
These are investments in entities where the company exercises significant influence but does not have full control. The...
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
equity_method_investments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.29B | $1.71B | $1.70B | $1.65B | $1.18B | $2.14B | $1.22B | $1.15B | $1.23B | $1.92B | $1.19B | $1.17B | $1.16B | $1.16B | $1.07B | $1.06B | $1.07B | $999.00M |
| QoQ Change | — | +32.2% | -0.4% | -2.9% | -28.3% | +80.7% | -43.0% | -5.9% | +7.6% | +55.9% | -38.1% | -1.3% | -1.1% | -0.4% | -7.6% | -0.9% | +0.9% | -6.5% |
| YoY Change | — | — | — | — | -8.4% | +25.3% | -28.3% | -30.5% | +4.2% | -10.1% | -2.3% | +2.5% | -5.8% | -39.8% | -10.2% | -9.9% | -8.0% | -13.6% |
We use cookies for analytics. See our Privacy and Cookie Policy.